ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

PoK: People protest in Gilgit Baltistan against Pak decision to lease land to China

Ghanche [PoK], Sept 22 (ANI): A mass protest took place in the Ghanche district of Pakistan occupied Kashmir (PoK) against the Islamabad's decision of leasing the pasture land of Gilgit Baltistan to China for mining.

ANI Sep 22, 2019 20:36 IST googleads

People protesting in PoK against against the Islamabad decision of lease the pasture land of Gilgit Baltistan to China for mining

Ghanche [PoK], Sept 22 (ANI): A mass protest took place in the Ghanche district of Pakistan occupied Kashmir (PoK) against the Islamabad's decision of leasing the pasture land of Gilgit Baltistan to China for mining.
The protestors blocked the road and accused Pakistan of violating state Subject Rule.
Member of the Gilgit Baltistan Legislative Assembly (GBLA) Mirza Hussain has said that 300 mining leases were awarded to China without "his knowledge".
"People of Ganache in occupied #GilgitBaltistan block Siachen Road to protest against leasing of their pasture to outsiders. GB minister for minerals says, 300 mining leases awarded without his knowledge. #Pakistani bureaucrats violating State Subject Rule in GB and world is silent," tweeted an activist Senge H Sering
Through its China Pakistan Economic Corridor (CPEC) initiative, Beijing is using transit routes of Gilgit Baltistan to reach Pakistan, Iran, Afghanistan and the ports along the coastline of Arabian Sea. Chinese mining companies control the region's much-valued mineral deposits of uranium, gold, copper, marble and precious stones.
However, the locals continue to resist China's ambitions. In 2008, for instance, a local person was killed when the residents of uranium-rich Gindai valley in Ghizer district clashed with Chinese miners.
Various human rights activists have raised their voices against the illegal occupation by China.
The CPEC project, which is a part of this initiative has been criticised by India since it passes through disputed Pakistan- occupied Kashmir (PoK) region. On the other hand, China has said that it had respected all territorial laws and that the issue was an "internal matter" between New Delhi and Islamabad. (ANI)



Get the App

What to Read Next

Asia

India rushes to safeguard 9,000 nationals in Iran

India rushes to safeguard 9,000 nationals in Iran

India on Thursday highlighted a high-level diplomatic push to protect Indian interests, emphasising the twin priorities of citizen safety and the stability of energy supply chains.

Read More
Europe

Blasphemy laws in Pakistan target religious minorities: GHRD

Blasphemy laws in Pakistan target religious minorities: GHRD

At the 61st session of the United Nations Human Rights Council, the organisation Global Human Rights Defence (GHRD) raised concerns over the continued misuse of blasphemy laws in Pakistan and their impact on religious minorities.

Read More
Asia

MEA rejects Pakistan’s statement on India-Canada deal

MEA rejects Pakistan’s statement on India-Canada deal

"We reject this statement made by Pakistan on the matter. India's credentials regarding non-proliferation are impeccable and well recognised by the global community. A country with a well-documented history of clandestine nuclear proliferation can hardly preach the virtues of export controls and proliferation risks. Such ludicrous statements are nothing more than an attempt by Pakistan to distract from its own abysmal record," he said.

Read More
Asia

India rejects Pakistan's "baseless allegations"

India rejects Pakistan's

India on Thursday rejected Pakistan's allegations of aggravating skirmishes with Afghanistan, calling them "baseless" and accusing Pakistan of blaming others for its own misdeeds.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.